Bowen Acquisition faces Nasdaq delisting risk after trust plunges to $8.3M, cash nearly gone

Snapshot - Bowen Acquisition Corp (NASDAQ: BOWN)

Quick summary: Bowen is a blank‑check (SPAC) vehicle that has sharply reduced its trust balance after mass redemptions, recorded mixed operating results in H1 2025 driven by non‑cash FPA accounting, and is facing Nasdaq listing and going‑concern pressure. Management is relying on related‑party funding and has extended the business‑combination deadline to December 14, 2025.

Key points & statistics
* Cash and cash equivalents (June 30, 2025): $17,556
* Investment held in Trust Account (June 30, 2025): $8,315,560 (vs $75,794,241 at Dec 31, 2024)
* Total assets (June 30, 2025): $8,514,688 (vs $76,048,300 at Dec 31, 2024)
* Total liabilities (June 30, 2025): $2,137,604
* Working capital deficit (June 30, 2025): $1,938,476 (shareholders' deficit)
* Ordinary shares outstanding (as of Aug 15, 2025): 2,994,371 ordinary shares (doc disclosure)
* Ordinary shares subject to possible redemption (June 30, 2025): $8,315,560 (744,473 shares at $11.17 redemption value)
* FPA (Prepaid Forward Purchase Agreement) - initial loss on issuance (Jan 2025): $1,929,656; change in fair value recognized through June 30, 2025: $1,123,154; FPA liability on balance sheet: $806,502
* Promissory note - related party outstanding (June 30, 2025): $500,000 (note includes amortized debt discount historically $209,442)
* Six months ended June 30, 2025 - net loss: $(1,289,691); six months interest income from trust: $185,727
* Three months ended June 30, 2025 - net income: $750,303; interest earned on trust (Q2): $88,405
* Basic/diluted EPS (three months ended June 30, 2025): redeemable $0.34; non‑redeemable $0.22

What's happening inside the company
* The company remains a SPAC that has not commenced operating revenues - all activity is transaction/formation and pursuit of the announced business combination with Qianzhi.
* Large public redemptions since the IPO dramatically reduced trust assets from ~$75.8M to ~$8.3M, leaving only modest cash on hand ($17.6k) outside the trust and a material working‑capital deficit.
* Management has executed extensions (most recently through Dec 14, 2025) and arranged related‑party support (extension deposits / promissory notes) to fund operations and meet obligations.
* The FPA created material non‑cash accounting impacts: a nearly $1.93M initial recognition loss and subsequent fair‑value volatility (net $1.123M reversal through June 30), producing profit/loss swings unrelated to core operations.
* Governance / control: management disclosed a material weakness in internal control (lack of qualified SEC reporting professional) and is undertaking remediation steps.
* Significant regulatory risk: subsequent events show Nasdaq issued deficiency notices, trading was halted and a delisting determination was issued (July 2025); the company intends to appeal and seek a stay, but outcome is uncertain.

Income statement - Positive aspects
* Q2 2025 reported net income of $750,303 (driven largely by non‑cash change in fair value of the FPA plus trust interest).
* Trust account continues to generate interest income (Q2 interest: $88,405; six‑month interest: $185,727) that supports the temporary equity value of redeemable shares.
* The FPA's fair‑value remeasurement produced a recognized gain in the quarter, improving reported earnings (non‑operational).

Income statement - Negative aspects
* H1 2025 net loss $(1,289,691) - driven by operating costs, interest expense (amortized debt discount), a large non‑cash loss on issuance of the FPA ($1,929,656) and financing expense ($336,000).
* Operating (formation and G&A) costs remain non‑trivial: six‑month operating costs $211,563.
* Reported earnings are volatile and heavily affected by one‑off, non‑operational, and Level‑3 fair‑value items (FPA), making core performance opaque.
* Low cash on hand ($17,556) and a shareholders' deficit raise solvency and going‑concern issues absent continued related‑party support or other financing.

Risks to watch (near term)
* Nasdaq delisting risk / trading suspension - immediate liquidity and access risk for public holders.
* Failure to complete the business combination by the extended deadline (Dec 14, 2025) - could trigger liquidation or further dilution/uncertainty.
* Dependence on related‑party loans and buyer(s) (FPA counterparty) - counterparty and execution risk.
* Fair‑value volatility of FPA liability - can produce large non‑cash swings in reported earnings and equity.

Bottom line
Bowen Acquisition Corp is a SPAC in a fragile position: it still holds a bridgeable trust balance (~$8.3M) and has strategies to extend the combination deadline, but cash outside the trust is nearly exhausted, the balance sheet shows a shareholders' deficit, and Nasdaq action plus going‑concern disclosures materially increase execution risk. The next 60-120 days (Nasdaq appeal outcome, any incremental funding, and progress toward closing the Qianzhi deal) will determine whether the company survives as a listed vehicle or faces liquidation/delisting.

Sources: Bowen Acquisition Corp Form 10‑Q (quarter ended June 30, 2025) - consolidated financial statements and subsequent events disclosures.